Abstract

The term "gestational diabetes mellitus" (GDM) refers to a form of carbohydrate intolerance that is initially identified during pregnancy and may have a negative impact on both the mother and the foetus. Aim: The purpose of the study was to ascertain the neonatal and maternal outcome in GDM cases. Materials and Methods: This study examines GDM-diagnosed women who received prenatal care and gave birth at our hospital. The 100-gram oral glucose challenge test, or ACOG recommendation, was used to diagnose GDM. Noted were several medical co-morbidities. Every woman was monitored until giving birth, and any difficulties were noted. In every instance, the baseline data (age, body mass index, parity, mode, and time of delivery) were recorded. Out of the 200 individuals that were screened for GDM, a total of 25 patients fulfilled the criteria for the disease. Results: The percentage of people with GDM was 12.5%. Twenty patients, or eighty percent, belonged to the 21–25 age range. Six instances included additional obstetric problems, and 76% of the cases had a BMI between 18.5 and 24.99. Women received insulin in 72% of cases. In eighty-six percent of the women, the glucose readings were within the acceptable range. 7 needed to be admitted to the ICU for newborns. 1 case had IUD and 1 had macrocosmic baby. New-borns of mothers whose GDM optimally treated had fewer complications. Conclusion: In this study, the prevalence of GDM was 12.5%. Maternal and newborn outcomes can be almost normal with appropriate treatment of GDM based on nutrition, oral hypoglycemic medications, or insulin to achieve euglycemia. For the most part, insulin was needed for therapy, and better blood glucose control led to fewer difficulties for newborns.

Description